{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:32:47Z","timestamp":1777721567183,"version":"3.51.4"},"reference-count":30,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2024-NHLHCRF-YS-01"],"award-info":[{"award-number":["2024-NHLHCRF-YS-01"]}]},{"name":"Capital's Funds for Health Improvement and Research","award":["2022-1-4062"],"award-info":[{"award-number":["2022-1-4062"]}]},{"name":"Beijing Research Ward Construction Clinical Research Project","award":["2022-YJXBF-04-03"],"award-info":[{"award-number":["2022-YJXBF-04-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Coronary artery disease (CAD) remains a fundamental etiology of morbidity and mortality among patients receiving dialysis, a cohort known to have a particularly poor prognosis. While traditional CAD risk factors, such as hyperlipidemia, hypertension, and diabetes, remain noteworthy, these factors do not fully capture the complexity of the disease in dialysis patients. Therefore, innovative and robust biomarkers that can refine risk stratification and enhance prognostic precision in this vulnerable population are imperative. Hence, this study aimed to evaluate the use of the red cell distribution width-to-albumin ratio (RAR) to predict clinical outcomes, particularly in dialysis patients with CAD. Methods: We analyzed data from a multicenter cohort of 1128 CAD patients on dialysis who were enrolled between January 2015 and June 2021. Patient stratification into tertiles was performed based on RARs. The primary endpoints were all-cause mortality and cardiovascular mortality. The secondary endpoint was the occurrence of major adverse cardiovascular events (MACEs), comprising non-fatal myocardial infarction, non-fatal stroke, and other cardiovascular events. Results: The median follow-up duration was 20.9 months 378 (33.5%) patients experienced all-cause mortality, 261 (19.1%) cardiovascular mortality, and 485 (43.0%) MACEs. In multivariable Cox proportional hazards regression, patients in the highest RAR tertile demonstrated remarkably escalated risks of all-cause mortality (hazard ratio (HR): 1.592, 95% confidence interval (CI): 1.212\u20132.092), cardiovascular mortality (HR: 1.503, 95% CI: 1.086\u20132.080), and MACEs (HR: 1.452, 95% CI: 1.141\u20131.846) compared with those in the lowest tertile. Moreover, restricted cubic spline analysis revealed a linear, dose-dependent association between elevated RAR and an increased risk of these adverse outcomes. The integration of the RAR into existing risk models, specifically the Global Registry of Acute Coronary Events and Gensini scores, noticeably amplified the predictive performance, as demonstrated by notable enhancements in both net reclassification improvement and integrated discrimination improvement. Conclusions: An elevated RAR serves as an independent predictor of poor outcomes in patients with CAD undergoing dialysis. Clinical Trial Registration: This study was registered at ClinicalTrials.gov (Identifier: NCT05841082; https:\/\/clinicaltrials.gov\/study\/NCT05841082).<\/jats:p>","DOI":"10.31083\/rcm47939","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:31:56Z","timestamp":1777458716000},"source":"Crossref","is-referenced-by-count":0,"title":["A New and Robust Prognostic Biomarker for Mortality Risk Prediction in Dialysis Patients With Coronary Artery Disease: Red Cell Distribution Width-to-Albumin Ratio"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6398-7397","authenticated-orcid":true,"given":"Xuecheng","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-7407","authenticated-orcid":true,"given":"Enmin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2988-1347","authenticated-orcid":true,"given":"Zhengqin","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-2181","authenticated-orcid":true,"given":"Di","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8942-9803","authenticated-orcid":true,"given":"Siqi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7171-6098","authenticated-orcid":true,"given":"Haoming","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5279-8145","authenticated-orcid":true,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-2251","authenticated-orcid":true,"given":"Lin","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chengdu Third People's Hospital, 610031 Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5160-4427","authenticated-orcid":true,"given":"Hesong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-6166","authenticated-orcid":true,"given":"Jingang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2013Japan Friendship Hospital, Affiliated With Capital Medical University, 100029 Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385: 1975\u20131982.","DOI":"10.1016\/S0140-6736(14)61601-9"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2019; 74: 1823\u20131838.","DOI":"10.1016\/j.jacc.2019.08.1017"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Li X, Xiao F, Zhang S. Coronary revascularisation in patients with chronic kidney disease and end-stage renal disease: A meta-analysis. International Journal of Clinical Practice. 2021; 75: e14506.","DOI":"10.1111\/ijcp.14506"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Hakeem A, Bhatti S, Chang SM. Screening and risk stratification of coronary artery disease in end-stage renal disease. JACC. Cardiovascular Imaging. 2014; 7: 715\u2013728.","DOI":"10.1016\/j.jcmg.2013.12.015"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Naki\u0107 D, Grbi\u0107 Pavlovi\u0107 P, Vojkovi\u0107 M, Stip\u0107evi\u0107 M, Patrk J, Bi\u0161tirli\u0107 M, et al. Coronary Artery Disease in Patients on Dialysis: Impact of Traditional Risk Factors. Medicina. 2024; 60: 1251.","DOI":"10.3390\/medicina60081251"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Jansz TT, van Reekum FE, \u00d6zyilmaz A, de Jong PA, Boereboom FTJ, Hoekstra T, et al. Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis. American Journal of Nephrology. 2018; 48: 369\u2013377.","DOI":"10.1159\/000494665"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Parizadeh SM, Jafarzadeh-Esfehani R, Bahreyni A, Ghandehari M, Shafiee M, Rahmani F, et al. The diagnostic and prognostic value of red cell distribution width in cardiovascular disease; current status and prospective. BioFactors. 2019; 45: 507\u2013516.","DOI":"10.1002\/biof.1518"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zhang T, Li J, Lin Y, Yang H, Cao S. Association Between Red Blood Cell Distribution Width and All-cause Mortality in Chronic Kidney Disease Patients: A Systematic Review and Meta-analysis. Archives of Medical Research. 2017; 48: 378\u2013385.","DOI":"10.1016\/j.arcmed.2017.06.009"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Flythe JE, Watnick S. Dialysis for Chronic Kidney Failure: A Review. JAMA. 2024; 332: 1559\u20131573.","DOI":"10.1001\/jama.2024.16338"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Polat N, Oylumlu M, I\u015fik MA, Arslan B, \u00d6zbek M, Demir M, et al. Prognostic Significance of Serum Albumin in Patients With Acute Coronary Syndrome. Angiology. 2020; 71: 903\u2013908.","DOI":"10.1177\/0003319720941747"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Gotsman I, Shauer A, Zwas DR, Tahiroglu I, Lotan C, Keren A. Low serum albumin: A significant predictor of reduced survival in patients with chronic heart failure. Clinical Cardiology. 2019; 42: 365\u2013372.","DOI":"10.1002\/clc.23153"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Gao J, Zhao Y, Du M, Guo H, Wan T, Wu M, et al. Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy. Neuropsychiatric Disease and Treatment. 2021; 17: 401\u2013411.","DOI":"10.2147\/NDT.S293771"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kimura H, Tanaka K, Saito H, Iwasaki T, Kazama S, Shimabukuro M, et al. Impact of red blood cell distribution width-albumin ratio on prognosis of patients with CKD. Scientific Reports. 2023; 13: 15774.","DOI":"10.1038\/s41598-023-42986-2"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ebert T, Neytchev O, Witasp A, Kublickiene K, Stenvinkel P, Shiels PG. Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients. Antioxidants & Redox Signaling. 2021; 35: 1426\u20131448.","DOI":"10.1089\/ars.2020.8184"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Namazi G, Heidar Beygi S, Vahidi MH, Asa P, Bahmani F, Mafi A, et al. Relationship Between Red Cell Distribution Width and Oxidative Stress Indexes in Patients with Coronary Artery Disease. Reports of Biochemistry & Molecular Biology. 2023; 12: 241\u2013250.","DOI":"10.61186\/rbmb.12.2.241"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Joosse HJ, van Oirschot BA, Kooijmans SAA, Hoefer IE, van Wijk RAH, Huisman A, et al. In-vitro and in-silico evidence for oxidative stress as drivers for RDW. Scientific Reports. 2023; 13: 9223.","DOI":"10.1038\/s41598-023-36514-5"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Patel KV, Mohanty JG, Kanapuru B, Hesdorffer C, Ershler WB, Rifkind JM. Association of the red cell distribution width with red blood cell deformability. Advances in Experimental Medicine and Biology. 2013; 765: 211\u2013216.","DOI":"10.1007\/978-1-4614-4989-8_29"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Gama-Axelsson T, Heimb\u00fcrger O, Stenvinkel P, B\u00e1r\u00e1ny P, Lindholm B, Qureshi AR. Serum albumin as predictor of nutritional status in patients with ESRD. Clinical Journal of the American Society of Nephrology. 2012; 7: 1446\u20131453.","DOI":"10.2215\/CJN.10251011"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Kologrivova I, Kercheva M, Panteleev O, Ryabov V. The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review. Biomedicines. 2024; 12: 2073.","DOI":"10.3390\/biomedicines12092073"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Yoshioka G, Tanaka A, Nishihira K, Natsuaki M, Kawaguchi A, Watanabe N, et al. Prognostic impact of follow-up serum albumin after acute myocardial infarction. ESC Heart Failure. 2021; 8: 5456\u20135465.","DOI":"10.1002\/ehf2.13640"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhu L, Chen M, Lin X. Serum albumin level for prediction of all-cause mortality in acute coronary syndrome patients: a meta-analysis. Bioscience Reports. 2020; 40: BSR20190881.","DOI":"10.1042\/BSR20190881"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Schupp T, Behnes M, Rusnak J, Ruka M, Dudda J, Forner J, et al. Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock? International Journal of Molecular Sciences. 2023; 24: 7375.","DOI":"10.3390\/ijms24087375"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ni Q, Wang X, Wang J, Chen P. The red blood cell distribution width-albumin ratio: A promising predictor of mortality in heart failure patients - A cohort study. Clinica Chimica Acta. 2022; 527: 38\u201346.","DOI":"10.1016\/j.cca.2021.12.027"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Zhao N, Hu W, Wu Z, Wu X, Li W, Wang Y, et al. The Red Blood Cell Distribution Width-Albumin Ratio: A Promising Predictor of Mortality in Stroke Patients. International Journal of General Medicine. 2021; 14: 3737\u20133747.","DOI":"10.2147\/IJGM.S322441"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Li D, Ruan Z, Wu B. Association of Red Blood Cell Distribution Width-Albumin Ratio for Acute Myocardial Infarction Patients with Mortality: A Retrospective Cohort Study. Clinical and Applied Thrombosis\/hemostasis. 2022; 28: 10760296221121286.","DOI":"10.1177\/10760296221121286"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Jian L, Zhang Z, Zhou Q, Duan X, Ge L. Red Cell Distribution Width\/Albumin Ratio: A Predictor of In-Hospital All-Cause Mortality in Patients with Acute Myocardial Infarction in the ICU. International Journal of General Medicine. 2023; 16: 745\u2013756.","DOI":"10.2147\/IJGM.S393393"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Liu Y, Sun S, Liu L. Association between the red blood cell distribution width-albumin ratio and cardiovascular diseases. Frontiers in Cardiovascular Medicine. 2025; 12: 1529533.","DOI":"10.3389\/fcvm.2025.1529533"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. Journal of the American Society of Nephrology. 2003; 14: 415\u2013424.","DOI":"10.1097\/01.asn.0000043140.23422.4f"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Hirsch D, Lau B, Kushwaha V, Yong K. The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review. Reviews in Cardiovascular Medicine. 2023; 24: 181.","DOI":"10.31083\/j.rcm2406181"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Wu J, Zhan X, Wen Y, Wang X, Feng X, Peng F, et al. Preexisting Cardiovascular Disease, Hypertension, and Mortality in Peritoneal Dialysis. Reviews in Cardiovascular Medicine. 2023; 24: 30.","DOI":"10.31083\/j.rcm2401030"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/4\/10.31083\/RCM47939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:32:33Z","timestamp":1777458753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/4\/10.31083\/RCM47939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)02653-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm47939","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"47939"}}